1. Home
  2. GEMI vs TSHA Comparison

GEMI vs TSHA Comparison

Compare GEMI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

N/A

Current Price

$7.22

Market Cap

1.2B

Sector

N/A

ML Signal

N/A

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$4.54

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEMI
TSHA
Founded
2014
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GEMI
TSHA
Price
$7.22
$4.54
Analyst Decision
Buy
Strong Buy
Analyst Count
9
9
Target Price
$14.50
$10.56
AVG Volume (30 Days)
1.6M
2.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.50
EPS
N/A
N/A
Revenue
N/A
$8,333,000.00
Revenue This Year
$21.99
N/A
Revenue Next Year
$76.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.57
$1.13
52 Week High
$34.67
$6.02

Technical Indicators

Market Signals
Indicator
GEMI
TSHA
Relative Strength Index (RSI) 45.39 46.71
Support Level $5.57 $4.39
Resistance Level $11.67 $5.16
Average True Range (ATR) 0.82 0.21
MACD 0.15 0.00
Stochastic Oscillator 36.59 31.17

Price Performance

Historical Comparison
GEMI
TSHA

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: